Diabetes & Endocrinology
Transoral Endocrine Surgery
Dr. Raymon Grogan, endocrine surgery section chief at Baylor St. Luke’s Medical Center and associate professor at Baylor College of Medicine, has completed over 150 TES procedures. Baylor St. Luke’s Medical Center is one of three high-volume academic thyroid- and parathyroid-focused surgical practices in the U.S. that studied 1,000 consecutive thyroid and parathyroid operations, determining more than half to be eligible for transoral endocrine surgery (TES).
The procedure is very unique because the surgeon goes through the inner lip to remove the thyroid, which leaves no sign of external scarring. The procedure also protects the parathyroid as an additional benefit.
Section Chief, Endocrine Surgery, Baylor St. Luke’s Medical Center
Leading Texas in Multidisciplinary Endocrinology and Endocrine Surgery Clinic Integration
Unparalleled Diabetes and Thyroid Cancer Research
The Section of Endocrinology, Diabetes and Metabolism at Baylor College of Medicine supports a robust biomedical research base. The Diabetes Research Center explores a vast range of diseases and conditions but focuses its efforts in four key areas: diabetes, metabolism, and nutrition research; the area of diabetes pathobiology and pathophysiology; the area of molecular lipid, glucose, and energy homeostasis; and the area of molecular endocrinology.
The next step is a two-year validation study including over 1,000 patients in the U.S., Brazil, and Australia.
Endocrine Surgeon, Baylor St. Luke’s Medical Center
Associate Professor and Chief of Endocrine Surgery, Baylor College of Medicine
The Pituitary Center at Baylor Medicine
The largest and busiest in Texas, the Pituitary Center cares for all pituitary-related disorders, including tumors of the pituitary and sellar region. The multidisciplinary team approach includes both endocrinologists and neurosurgeons working to develop and place patients on clinical trials aimed at establishing new therapies for pituitary tumors.
Cynthia’s Story: Living Cancer and Scar-Free
Cynthia was familiar with her papillary thyroid cancer, because it had affected several members of her family before. She knew her cancer was treatable with surgery, but she had witnessed the side effects. She wanted to avoid trouble with her voice and the scar on her throat so she began to hunt for scarless thyroid surgery. She chose to visit Dr. Raymon Grogan, section chief of endocrine surgery at Baylor St. Luke’s Medical Center, one of the only doctors in the U.S. that performs transoral thyroidectomy, or TOETVA—a scarless thyroid surgery that allows for the safe and total removal of the thyroid or parathyroid glands without any external scarring to the neck. Shortly after surgery, Cynthia was informed her cancer was entirely removed with negative surgical margins.
Mechanism Reprograms Endocrine-Resistant Breast Cancer to Become Metastatic
Researchers at Dan L Duncan Comprehensive Cancer Center, in partnership with Baylor College of Medicine and Harvard Medical School, have unveiled a new mechanism to help explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new therapeutic strategies. These findings reveal details of the intricate mechanism FOXA1 triggers to induce metastatic behavior in endocrine-resistant breast cancer, which other reports have suggested also is present in other types of cancer, such as prostate and pancreatic cancer. In addition, the findings support further exploration of the possibility that inhibiting HIF-2a or other enhancer that controls the expression of many genes in endocrine therapy-resistant breast cancer could be translated into effective therapeutic strategies.